← Open Payments lookup

LINDA DEMO: Open Payments

NPI 1366944399 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$743 in 28 payments from 12 companies in 2025. Trend: 2023 $124 · 2024 $129 · 2025 $743

Food & beverage: $743
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$160
Neurocrine BioSciences, Inc.1$128
Alkermes, Inc.1$110
Axsome Therapeutics, Inc.4$95
Collegium Pharmaceutical, Inc.4$64
Janssen Pharmaceuticals, Inc2$53
Tris Pharma Inc2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
ABBVIE INC.1$16
Noven Therapeutics, LLC1$15

Products named: REXULTI, INGREZZA, LYBALVI, Auvelity, Jornay PM, SPRAVATO, Dyanavel XR, CAPLYTA.

Industry payments across IN — which companies pay providers there.